PL1709103T3 - Biodegradable multi-block co-polymers - Google Patents

Biodegradable multi-block co-polymers

Info

Publication number
PL1709103T3
PL1709103T3 PL05704550T PL05704550T PL1709103T3 PL 1709103 T3 PL1709103 T3 PL 1709103T3 PL 05704550 T PL05704550 T PL 05704550T PL 05704550 T PL05704550 T PL 05704550T PL 1709103 T3 PL1709103 T3 PL 1709103T3
Authority
PL
Poland
Prior art keywords
polymers
block
biodegradable multi
biodegradable
Prior art date
Application number
PL05704550T
Other languages
English (en)
Inventor
Catharina Everdina Hissink
Rob Steendam
Ronald Meyboom
Theodorus Adrianus Cornelius Flipsen
Original Assignee
Innocore Technologies B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innocore Technologies B.V. filed Critical Innocore Technologies B.V.
Publication of PL1709103T3 publication Critical patent/PL1709103T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10—Definition of the polymer structure
    • C08G2261/12—Copolymers
    • C08G2261/126—Copolymers block
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/139—Open-ended, self-supporting conduit, cylinder, or tube-type article

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
PL05704550T 2004-01-15 2005-01-14 Biodegradable multi-block co-polymers PL1709103T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075099A EP1555278A1 (en) 2004-01-15 2004-01-15 Biodegradable multi-block co-polymers

Publications (1)

Publication Number Publication Date
PL1709103T3 true PL1709103T3 (pl) 2017-01-31

Family

ID=34610205

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05704550T PL1709103T3 (pl) 2004-01-15 2005-01-14 Biodegradable multi-block co-polymers

Country Status (11)

Country Link
US (2) US8481651B2 (pl)
EP (2) EP1555278A1 (pl)
JP (1) JP4907359B2 (pl)
CN (1) CN1910217B (pl)
AU (1) AU2005205409B2 (pl)
CA (1) CA2553619C (pl)
DK (1) DK1709103T3 (pl)
ES (1) ES2599035T3 (pl)
HU (1) HUE031648T2 (pl)
PL (1) PL1709103T3 (pl)
WO (1) WO2005068533A1 (pl)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US8747879B2 (en) * 2006-04-28 2014-06-10 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device to reduce chance of late inflammatory response
US8357391B2 (en) 2004-07-30 2013-01-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
EP2298829B1 (en) * 2005-05-31 2017-09-20 École Polytechnique Fédérale de Lausanne (EPFL) Triblock copolymers for cytoplasmic delivery of gene-based drugs
US20070162110A1 (en) 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices
US20070224234A1 (en) * 2006-03-22 2007-09-27 Mark Steckel Medical devices having biodegradable polymeric regions
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CA2657533A1 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
DE102006039346A1 (de) * 2006-08-22 2008-03-13 Biotronik Vi Patent Ag Biokorrodierbares metallisches Implantat mit einer Beschichtung oder Kavitätenfüllung aus einem PEG/PLGA-Copolymer
KR100795214B1 (ko) 2006-08-22 2008-01-21 이화여자대학교 산학협력단 온도 민감성 졸-젤 전이 폴리(에틸렌글리콜)/폴리(카보네이트) 블록 공중합체 및 이의 제조방법
ES2727010T3 (es) * 2006-09-29 2019-10-11 Total Research & Tech Feluy Sa Copolímeros de polilactida-uretano
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2098256B1 (en) * 2006-11-17 2016-06-08 National Cerebral and Cardiovascular Center Blood-coagulation inhibiting material, coating material and in vivo indwelling members made by using the material, and method of treatment
CN100535033C (zh) * 2007-02-13 2009-09-02 四川大学 一种聚乳酸嵌段共聚物及其制备方法
US8709827B2 (en) 2007-06-28 2014-04-29 Surmodics, Inc. Polypeptide microparticles
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
CN100558786C (zh) * 2007-08-02 2009-11-11 同济大学 一种聚乳酸基嵌段共聚物的制备方法
US8661630B2 (en) 2008-05-21 2014-03-04 Abbott Cardiovascular Systems Inc. Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
US20090104241A1 (en) * 2007-10-23 2009-04-23 Pacetti Stephen D Random amorphous terpolymer containing lactide and glycolide
US8642062B2 (en) 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
WO2009091812A2 (en) * 2008-01-14 2009-07-23 Surmodics, Inc. Devices and methods for elution of nucleic acid delivery complexes
US8501290B2 (en) 2008-01-15 2013-08-06 Abbott Cardiovascular Systems Inc. Implantable medical devices fabricated from polyurethanes with biodegradable hard and soft blocks and blends thereof
DE102008006455A1 (de) * 2008-01-29 2009-07-30 Biotronik Vi Patent Ag Implantat mit einem Grundkörper aus einer biokorrodierbaren Legierung und einer korrosionshemmenden Beschichtung
US8951545B2 (en) 2008-03-28 2015-02-10 Surmodics, Inc. Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
US20090263449A1 (en) * 2008-04-09 2009-10-22 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
US9259515B2 (en) * 2008-04-10 2016-02-16 Abbott Cardiovascular Systems Inc. Implantable medical devices fabricated from polyurethanes with grafted radiopaque groups
US8916188B2 (en) * 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
US20090285873A1 (en) * 2008-04-18 2009-11-19 Abbott Cardiovascular Systems Inc. Implantable medical devices and coatings therefor comprising block copolymers of poly(ethylene glycol) and a poly(lactide-glycolide)
CA2723192A1 (en) * 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
JP2011528038A (ja) * 2008-07-14 2011-11-10 サーモディクス，インコーポレイテッド 医療用デバイスおよび核酸の送達方法
GB0819296D0 (en) * 2008-10-21 2008-11-26 Smith & Nephew Coating II
WO2010068432A1 (en) 2008-11-25 2010-06-17 Ecole Polytechnique Federale De Lausanne (Epfl) Block copolymers and uses thereof
US8668919B2 (en) * 2009-03-03 2014-03-11 Abbott Cardiovascular Systems Inc. Polymer for creating hemocompatible surface
JP5574445B2 (ja) * 2009-03-06 2014-08-20 国立大学法人 岡山大学 生分解性多孔質中空微粒子、その製造方法および用途
EP2416762A2 (en) * 2009-04-08 2012-02-15 SurModics, Inc. Controlled release devices and methods for delivery of nucleic acids
US8883208B2 (en) * 2009-04-08 2014-11-11 Surmodics, Inc. Particles for delivery of nucleic acids and related devices and methods
US8147744B2 (en) * 2009-04-10 2012-04-03 Abbott Cardiovascular Systems Inc. Method of making a stent formed from crosslinked bioabsorbable polymer
US8246576B2 (en) 2009-05-18 2012-08-21 Surmodics, Inc. Method and apparatus for delivery of a therapeutic agent with an expandable medical device
US20120269924A1 (en) * 2009-09-10 2012-10-25 David Phillips Chewing gums having improved removability based on linear viscoelastic shear rheology
WO2011035261A1 (en) * 2009-09-18 2011-03-24 Protherics Salt Lake City, Inc. Reconstitutable reverse thermal gelling polymers
US9155722B2 (en) * 2009-09-18 2015-10-13 Protherics Salt Lake City, Inc. Reconstitutable reverse thermal gelling polymers
ES2626929T3 (es) * 2009-09-18 2017-07-26 Protherics Medicines Development Limited Polímeros tribloque bab que tienen características de liberación mejoradas
CA2792771A1 (en) 2010-03-12 2011-09-15 Surmodics, Inc. Injectable drug delivery system
EP2569023B1 (en) 2010-05-10 2015-10-21 SurModics, Inc. Glycerol ester active agent delivery systems and methods
US20110319473A1 (en) 2010-06-29 2011-12-29 Surmodics, Inc. Compositions and methods for enhancement of nucleic acid delivery
CA2803361C (en) 2010-06-30 2020-07-21 Surmodics, Inc. Lipid coating for medical devices delivering bioactive agent
US10596355B2 (en) 2010-06-30 2020-03-24 Surmodics, Inc. Catheter assembly
ES2628931T3 (es) 2010-07-09 2017-08-04 Innocore Technologies B.V. Copolímeros multibloque segmentados de fases separadas biodegradables y liberación de polipétidos biológicamente activos
US8936740B2 (en) 2010-08-13 2015-01-20 Kimberly-Clark Worldwide, Inc. Modified polylactic acid fibers
US10753023B2 (en) 2010-08-13 2020-08-25 Kimberly-Clark Worldwide, Inc. Toughened polylactic acid fibers
US8961457B2 (en) 2010-09-30 2015-02-24 Surmodics, Inc. Catheter assembly with guard
WO2012058274A2 (en) 2010-10-26 2012-05-03 Surmodics, Inc. Coatings and methods for controlled elution of hydrophilic active agents
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
WO2012092421A2 (en) 2010-12-30 2012-07-05 Surmodics, Inc. Composition for intravascular delivery of therapeutic composition
AU2012225286B2 (en) * 2011-03-09 2015-03-12 Regents Of The University Of Minnesota Chewing gums and gum bases comprising multi-block copolymers
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
US9012596B2 (en) * 2011-06-16 2015-04-21 Vanderbilt University Copolymers and methods of use thereof
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
GB201110601D0 (en) * 2011-06-23 2011-08-03 Controlled Therapeutics Scotland Ltd Improved bioresorbable
MY169349A (en) * 2011-07-22 2019-03-21 Innocore Tech B V Biodegradable, semi-crystalline, phase separated, thermoplastic multi-block copolymers for controlled release of biologically active compounds
JP5835769B2 (ja) * 2011-09-12 2015-12-24 国立大学法人秋田大学 親水性多孔質膜及びその製造方法、並びに、医療用癒着防止膜及び細胞増殖用基材
US9526603B2 (en) * 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
CN103113561B (zh) * 2011-10-12 2014-08-06 苏州莫立克新型材料有限公司 一种可快速降解的聚酯类聚合物及其制备方法和应用
US20130236499A1 (en) * 2012-03-12 2013-09-12 Sasa Andjelic Segmented, Semicrystalline Poly(Lactide-co-epsilon-Caprolactone) Absorbable Copolymers
EP2873455B1 (en) * 2012-07-12 2021-07-07 Takeda Pharmaceutical Company Limited Method for manufacturing microcapsule powder
CA2883768A1 (en) * 2012-09-07 2014-03-13 Wm. Wrigley Jr. Company Improved gum bases and chewing gums employing block polymers and processes for preparing them
JP6438406B2 (ja) 2012-11-05 2018-12-12 サーモディクス，インコーポレイテッド 疎水性生理活性物質を送達するための組成物および方法
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
WO2014088320A1 (ko) 2012-12-04 2014-06-12 주식회사 엘지화학 연신 필름
FI128487B (en) * 2013-05-06 2020-06-15 Teknologian Tutkimuskeskus Vtt Oy Glycolic acid polymers and process for their preparation
US10711106B2 (en) 2013-07-25 2020-07-14 The University Of Chicago High aspect ratio nanofibril materials
US9714318B2 (en) * 2013-07-26 2017-07-25 Stratasys, Inc. Polyglycolic acid support material for additive manufacturing systems
JO3394B1 (ar) 2014-07-04 2019-10-20 Osteo Pharma B V تركيبات ومنتجات للاستعمال في علاج كسور وعيوب العظام
WO2016097002A1 (en) * 2014-12-17 2016-06-23 Purac Biochem Bv Substrates coated or bonded with a composition comprising a polyurethane
CN104744661A (zh) * 2015-03-03 2015-07-01 宁波市医疗中心李惠利医院 一种亲水性、可降解的嵌段聚氨酯及其制备方法和用途
US10086109B2 (en) * 2015-06-02 2018-10-02 Ethicon, Inc. Absorbable medical devices based on novel films and foams made from semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics
US9896560B2 (en) 2015-06-02 2018-02-20 Ethicon, Inc. Lyophilized foams of end block containing absorbable polymers
US10905792B2 (en) * 2015-10-19 2021-02-02 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patch
US11471556B2 (en) 2015-10-19 2022-10-18 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patch
JP6816135B2 (ja) * 2015-10-19 2021-01-20 シーレーンチウム メディカル リミテッド フィブリノーゲンに基づく改善された組織接着剤パッチ
US20170281914A1 (en) 2016-03-31 2017-10-05 Surmodics, Inc. Localized treatment of tissues through transcatheter delivery of active agents
US10098846B2 (en) 2016-03-31 2018-10-16 Surmodics, Inc. Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
CN106730023A (zh) * 2016-12-20 2017-05-31 上海纳米技术及应用国家工程研究中心有限公司 一种多聚磷酸钙改性ipdi‑pclla‑peg‑pclla多孔支架及制备和应用
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
HUE058207T2 (hu) 2017-01-31 2022-07-28 Veru Inc Készítmények és módszerek gonadotropin felszabadító hormon (GNRH) antagonisták elnyújtott idejû felszabadítására
CN107261217A (zh) * 2017-07-25 2017-10-20 新乡医学院三全学院 一种生物可吸收高分子神经导管支架及制备方法
CA3086446A1 (en) 2017-12-20 2019-06-27 Stryker European Holdings I, Llc Biomedical foam
CN108330088A (zh) * 2018-02-28 2018-07-27 武汉天度植物科技有限公司 固体微生物菌剂及其制备方法
EP3781384A4 (en) * 2018-04-19 2022-01-26 Poly-Med Inc. MACROMERS AND COMPOSITIONS FOR PHOTOCURING PROCESSES
US11058792B2 (en) 2018-06-28 2021-07-13 Ethicon, Inc. Readily absorbable copolymer compositions for high strength sutures having enhanced strength retention post-implantation
WO2020087203A1 (en) * 2018-10-29 2020-05-07 Pujing Chemical Industry Co., Ltd Heat and aging resistant polyglycolide copolymer and composition thereof
CN109651940A (zh) * 2018-11-14 2019-04-19 浙江海洋大学 水产养殖网箱防污涂料
KR102292781B1 (ko) * 2018-12-28 2021-08-25 한양대학교 에리카산학협력단 폴리글리콜리드-폴리락티드 다중블록공중합체 수지 및 그 제조방법
KR102249223B1 (ko) * 2018-12-28 2021-05-07 성균관대학교산학협력단 고강도 인체흡수성 폴리글리콜산계 블록공중합체 수지 및 이의 제조 방법
CN110105550A (zh) * 2019-05-23 2019-08-09 华南理工大学 一种高机械性能生物相容性共聚物及制备方法与应用
US11478815B2 (en) 2020-01-16 2022-10-25 Surmodics, Inc. Coating systems for medical devices
KR20230005125A (ko) * 2020-02-21 2023-01-09 네이쳐웍스 엘엘씨 저 분자량 비정질 등급 폴리락트산 수지를 함유하는 화장료 조성물
CA3180971A1 (en) 2020-04-22 2021-10-28 Scienture, Inc. Long-acting bupivacaine microsphere formulations
JP7512695B2 (ja) 2020-06-08 2024-07-09 東レ株式会社 ポリエステルコポリマー
CN114276511B (zh) * 2022-01-10 2023-08-18 浙江海正生物材料股份有限公司 一种支化嵌段共聚物及其制备方法
AU2023235001A1 (en) 2022-03-17 2024-10-17 InnoCore Technologies Holding B.V. Biodegradable thermoplastic poly(ortho ester) based multiblock copolymers
WO2024069235A2 (en) 2022-09-30 2024-04-04 Sixfold Bioscience Ltd. Compositions containing oligonucleotides with theranostic applications

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806658A (en) * 1982-11-15 1989-02-21 The Dow Chemical Company Cleavage of polyethylene glycol ethers by hydrolysis
US5202413A (en) * 1993-02-16 1993-04-13 E. I. Du Pont De Nemours And Company Alternating (ABA)N polylactide block copolymers
EP0696605B1 (de) 1994-08-10 2000-09-20 Peter Neuenschwander Biokompatibles Blockcopolymer
US6413539B1 (en) * 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
JP3443603B2 (ja) * 1995-10-03 2003-09-08 トヨタ自動車株式会社 ポリ乳酸ブロック共重合体組成物、その製造方法及び成型品
IT1282585B1 (it) * 1996-02-08 1998-03-31 Europ Copolimeri a blocchi poliesterepolicarbonato contenenti segmenti di poli(caprolattone)e loro uso per la preparazione di matrici
CN1225014A (zh) * 1996-07-11 1999-08-04 生命医学科学公司 减少或消除术后粘着形成的方法和组合物
US5711958A (en) 1996-07-11 1998-01-27 Life Medical Sciences, Inc. Methods for reducing or eliminating post-surgical adhesion formation
JPH1046013A (ja) * 1996-07-31 1998-02-17 Sekisui Chem Co Ltd 生分解性樹脂組成物
US6211249B1 (en) * 1997-07-11 2001-04-03 Life Medical Sciences, Inc. Polyester polyether block copolymers
JP4074908B2 (ja) * 1997-07-17 2008-04-16 大日本インキ化学工業株式会社 高分子量乳酸系ポリエーテル共重合体の製造方法
KR20010030891A (ko) * 1997-10-03 2001-04-16 마크로메드 인코퍼레이션 가역적 열 겔화 성질을 갖는 생분해성 저분자량 트리블럭폴리(락티드-코-글리콜리드) 폴리에틸렌 글리콜 공중합체
US6267987B1 (en) * 1997-12-12 2001-07-31 Samyang Corporation Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake
US6160084A (en) * 1998-02-23 2000-12-12 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US7326425B2 (en) * 1999-12-31 2008-02-05 Rutgers, The State University Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
JP4745540B2 (ja) 2001-06-15 2011-08-10 昭和電工株式会社 生分解性水分散系接着剤組成物
KR100448170B1 (ko) * 2001-06-23 2004-09-10 주식회사 태평양 폴리에틸렌이민을 친수성 블록으로 갖고 폴리에스테르계고분자를 소수성 블록으로 갖는 양친성 생분해성 블록공중합체 및 이를 이용한 수용액 상에서의 고분자자기조합 회합체
KR100453130B1 (ko) 2001-11-21 2004-10-15 한국과학기술연구원 구조적 배열이 일정한 생분해성 락타이드(글리콜라이드또는 락타이드/글리콜라이드)/ε-카프로락톤 멀티블록공중합체 및 이의 제조 방법
WO2003080119A1 (en) * 2002-03-26 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Responsive biomedical composites
DK1498147T3 (da) 2003-07-16 2015-05-26 Eidgenössische Tech Hochschule Zürich Nedbrydelig biokompatibel blokcopolymer

Also Published As

Publication number Publication date
EP1709103B1 (en) 2016-07-20
JP2007522274A (ja) 2007-08-09
ES2599035T3 (es) 2017-01-31
AU2005205409B2 (en) 2010-05-13
CN1910217B (zh) 2012-06-20
EP1709103A1 (en) 2006-10-11
US8674032B2 (en) 2014-03-18
CA2553619C (en) 2012-08-14
EP1555278A1 (en) 2005-07-20
US20070155906A1 (en) 2007-07-05
JP4907359B2 (ja) 2012-03-28
HUE031648T2 (en) 2017-07-28
CA2553619A1 (en) 2005-07-28
US8481651B2 (en) 2013-07-09
CN1910217A (zh) 2007-02-07
AU2005205409A1 (en) 2005-07-28
US20130273284A1 (en) 2013-10-17
WO2005068533A1 (en) 2005-07-28
DK1709103T3 (en) 2016-10-31

Similar Documents

Publication Publication Date Title
PL1709103T3 (pl) Biodegradable multi-block co-polymers
GB2444443B (en) Knitting techniques
AP2583A (en) Gabion
GB2432610B (en) Gabion
IL182405A0 (en) Mouldable biodegradable polymer
GB2420522B (en) Shift device
EP1723275A4 (en) BIODEGRADABLE NETWORK
GB2427866B (en) Pentathienyl-fluorene copolymer
GB2412111B (en) Polymeric void-board
IL183137A0 (en) Polymeric nano-shells
GB0423212D0 (en) Polymer
GB0523927D0 (en) Gabion
GB0417033D0 (en) Sheeting
GB0516199D0 (en) Improved aminophosphinate co-polymers
GB0520310D0 (en) Improved aminophosphinate co-polymers
PL371308A1 (pl) Smar biodegradowalny
GB0412118D0 (en) Manhole friendly
GB0424321D0 (en) Gabion
GB0424322D0 (en) Gabion
GB0427565D0 (en) State selector
GB0422070D0 (en) Microorganism
GB0510148D0 (en) Gabions
GB0508481D0 (en) Gabion
GB0523926D0 (en) Gabion
GB0503078D0 (en) Gabion